NCT05609058

Brief Summary

Radiotherapy after breast conserving therapy plays an important role in early stage breast cancer patients. It not only results in a reduction in local and regional recurrence but also decrease the death rate effectively. For adjuvant radiotherapy, supine positioning is the most common approach and has multiple advantages. Due to deformability and softness of the breast, during simulation and treatment in supine position, the breast stretches over the chest wall, especially in patients with large and pendulous glands. Thus the organs at risk (OARs) received dose increased. The radiotherapeutic toxicity are unavoidable. Some present studies show that the prone positioning of patients can improve dose homogeneity and reduce the dose distribution in OARs in patients with large and pendulous glands. Chinese women have relatively small breasts, the advantages of those have not been established. Therefore, investigators compared the parameters between supine and prone positions for whole breast irradiation after conserving surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started Jan 2019

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2019

Completed
3.8 years until next milestone

First Submitted

Initial submission to the registry

October 24, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 8, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

January 31, 2023

Status Verified

January 1, 2023

Enrollment Period

4.8 years

First QC Date

October 24, 2022

Last Update Submit

January 28, 2023

Conditions

Keywords

Breast cancerradiotherapy

Outcome Measures

Primary Outcomes (6)

  • dose distribution of GTV

    the difference of GTV (Gross tumor target) between two plans

    1 year

  • dose distribution of CTV

    the difference of CTV (clinical target volume) between two plans

    1 year

  • dose distribution of PTV

    the difference of PTV (planing target volume) between two plans

    1 year

  • dose distribution of heart

    the difference of heart dose distribution between two plans

    1 year

  • dose distribution of ipsilateral lung

    the difference of ipsilateral lung dose distribution between two plans

    1 year

  • dose distribution of bilateral breasts

    the difference of bilateral breasts dose distribution between two plans

    1 year

Study Arms (1)

Breast cancer underwent scanning in the supine position

EXPERIMENTAL

Breast cancer patients with T1-2N0M0 stage who underwent radiation therapy after conserving surgery were enrolled. Supine scan sets were acquired during free breathing for all patients. Target volumes and organs at risk (OARs) including heart, ipsilateral lung and bilateral breast were contoured by the same radiation oncologist. The tumor bed (TB) was determined based on surgical clips. The Clinical target volume (CTV)consisted of the whole breast. The planning target volume (PTV) was CTV plus 0.5cm. The boost of PTV (PTVboost) was TB plus 0.5cm.

Device: dedicated treatment board with no degree

Interventions

the patients were placed in the prone position on a dedicated treatment board with no degree incline using an arm support (with both arms above the head). Te board contained an open aperture on one side to allow for the ipsilateral breast to hang freely away from the chest wall

Breast cancer underwent scanning in the supine position

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Breast cancer patients with T1-T2N0M0 stage who underwent radiation therapy after conserving surgery
  • exhibited normal arm movement aſter surgery
  • had no chronic lung diseases
  • Written informed consent forms

You may not qualify if:

  • Breast cancer patients with radical surgery
  • could not exhibit normal arm movement after surgery
  • had chronic lung diseases
  • refused informed consent forms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanxi provicial cancer hospital

Taiyuan, Shanxi, 030001, China

RECRUITING

Related Publications (1)

  • Ma L, Yang Y, Ma J, Mao L, Li X, Feng L, Abulimiti M, Xiang X, Fu F, Tan Y, Zhang W, Li YX, Jin J, Li N. Correlation between AI-based CT organ features and normal lung dose in adjuvant radiotherapy following breast-conserving surgery: a multicenter prospective study. BMC Cancer. 2023 Nov 9;23(1):1085. doi: 10.1186/s12885-023-11554-2.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Breast cancer patients with T1-T2N0M0 stage who underwent radiation therapy after conserving surgery were enrolled. Supine and Prone scan sets were acquired during free breathing for all patients. Target volumes and organs at risk (OARs) including heart, ipsilateral lung and bilateral breast were contoured by the same radiation oncologist.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

October 24, 2022

First Posted

November 8, 2022

Study Start

January 1, 2019

Primary Completion

November 1, 2023

Study Completion

November 1, 2023

Last Updated

January 31, 2023

Record last verified: 2023-01

Locations